risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack

RxCUI: 1020065
RxNorm name: risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack
Display name: risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack
Full name: risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atelvia	RISEDRONATE SODIUM	Allergan, Inc.	c8b9ab88-1a26-46c3-80ec-4eaa45202021	2026-02-03	Warnings, Adverse reactions	Exact identifier rxcui: 1020065
Risedronate Sodium	RISEDRONATE SODIUM	Mylan Pharmaceuticals, Inc.	c89430be-15f1-4b8b-ab7e-738de716ee7d	2026-02-03	Warnings, Adverse reactions	Exact identifier rxcui: 1020065
RISEDRONATE SODIUM	RISEDRONATE SODIUM	Sun Pharmaceutical Industires Inc.	1d9e520b-2fa6-4603-b397-f0fc24fae775	2020-09-09	Warnings, Adverse reactions	Exact identifier rxcui: 1020065

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c8b9ab88-1a26-46c3-80ec-4eaa45202021	{4 (risedronate sodium 35 MG Delayed Release Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack [PSN]	2	29	These highlights do not include all the information needed to use ATELVIA safely and effectively. See full prescribing information for ATELVIA . ATELVIA ® (risedronate sodium) delayed-release tablets Initial U.S. Approval: 1998	20260203
c89430be-15f1-4b8b-ab7e-738de716ee7d	{4 (risedronate sodium 35 MG Delayed Release Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack [PSN]	2	7	These highlights do not include all the information needed to use RISEDRONATE SODIUM DELAYED-RELEASE safely and effectively. See full prescribing information for RISEDRONATE SODIUM DELAYED-RELEASE . RISEDRONATE SODIUM DELAYED-RELEASE tablets Initial U.S. Approval: 1998	20260203
1d9e520b-2fa6-4603-b397-f0fc24fae775	{4 (risedronate sodium 35 MG Delayed Release Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG Delayed Release Oral Tablet 4 Count Pack [PSN]	2	4	These highlights do not include all the information needed to use RISEDRONATE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM DELAYED-RELEASE TABLETS. RISEDRONATE SODIUM delayed-release tablets, for oral use Initial U.S. Approval: 1998	20200909